Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |